Indaptus Therapeutics Files Prospectus Related To The Proposed Resale Of Up To 58,895,000 Shares Of Common Stock By Selling Stockholders

Benzinga Newsdesk www.benzinga.com Neutral 93.2%

Neg 0% Neu 93.2% Pos 0%

https://www.sec.gov/Archives/edgar/data/1857044/000149315226038780/forms-3.htm

Comments

No comments yet. Be the first!